-
公开(公告)号:US20230125432A1
公开(公告)日:2023-04-27
申请号:US17974331
申请日:2022-10-26
Applicant: TAE Life Sciences, LLC
Inventor: Charles Lee , Jedediah Styron
Abstract: Systems, devices, and methods for converting a raw neutron beam to a specified deliverable format having a targeted energy range, size, and direction are described. Embodiments of a neutron beam converter can include numerous regions based on location, function, dimension, and/or constituent material. The regions can include a central region, an intermediate region, a peripheral region, and a frontal region. Materials are also described.
-
2.
公开(公告)号:US20250034176A1
公开(公告)日:2025-01-30
申请号:US18892994
申请日:2024-09-23
Applicant: TAE Life Sciences LLC
Inventor: Michael Y. Torgov , Tioga J. Martin , Arthur B. Raitano
Abstract: Borylated Amino Acid (“BAA”) compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders and other disease by utilizing a Neutron Capture Therapy modality.
-
3.
公开(公告)号:US20250059215A1
公开(公告)日:2025-02-20
申请号:US18796638
申请日:2024-08-07
Applicant: TAE Life Sciences LLC
Inventor: Jason C. Quintana , Tioga Martin
Abstract: Trifluoroborate (BF3) Compounds (“BF3 compounds”) and methods of making BF3 compounds are disclosed herein. Consequently, the BF3 compounds can be administered to patients as a Neutron Capture Agent or as a single agent or in combination with other BF3 compounds and provide a method of treating cancer, immunological disorders, and other disease by utilizing various treatment modalities.
-
公开(公告)号:US20240066323A1
公开(公告)日:2024-02-29
申请号:US18239568
申请日:2023-08-29
Applicant: TAE Life Sciences, LLC
Inventor: Jedediah Styron , Jonathan David McCoy , Charles Leon Lee , Matthew Alan Core
CPC classification number: A61N5/1071 , A61N5/1067 , G01T7/005 , G01T3/00
Abstract: A method for monitoring and controlling neutron beams includes performing a calibration process for a monitoring dosimeter at a first set of conditions for directing a neutron beam towards an object location, the neutron beam being emitted from a neutron-generating target in response to an incident charged particle beam, the process comprising: obtaining data indicating a first neutron flux measured by the monitoring dosimeter between the monitoring dosimeter and the object location, the monitoring dosimeter offset from the axis by a distance equal to or greater than the beam radius; obtaining data indicating a second neutron flux measured by a reference dosimeter between the target and the object location; storing calibration data including a correlation between the first neutron flux and the second neutron flux; and based on the calibration data, using the monitoring dosimeter to monitor neutron flux incident on a patient during boron neutron capture therapy treatment.
-
公开(公告)号:US20240120126A1
公开(公告)日:2024-04-11
申请号:US18479714
申请日:2023-10-02
Applicant: TAE Life Sciences, LLC
Inventor: Charles Leon Lee , Jedediah Styron , Matthew Alan Core , Mark Joseph Rouillard , Vijay Patel
Abstract: Systems, devices, and methods for collimating a neutron beam to specified deliverable formats having targeted beam diameters and direction are described. Examples of a neutron collimator assembly can include numerous components based on location, function, dimension, and/or constituent material. The components can include, neutron beam collimators, a beam stop, a mounting assembly, electro-mechanical actuators, an electronic controller, a safety interlock system, a moveable radiation shield, a safety cover, and an adjustable patient platform. In addition, examples of variable aperture neutron beam collimators such as nested neutron beam collimators and collimators with a diaphragm iris are described. Materials are also described.
-
-
-
-